Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

about

Mastocytosis: from a Molecular Point of View.

P2860

Q39446801-0EDA597C-E94A-4752-9943-83086E3C65E8

P2860

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

Item

http://www.wikidata.org/entity/Q42362452

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@en

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@nl

type

Item

label

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@en

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@nl

prefLabel

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@en

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@nl

P1476

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

@en

P2093

Farshad Aduli

http://www.w3.org/2001/XMLSchema#string

Jagpal S Klair

http://www.w3.org/2001/XMLSchema#string

Johnny Jones

http://www.w3.org/2001/XMLSchema#string

Mohit Girotra

http://www.w3.org/2001/XMLSchema#string

Naga S Addepally

http://www.w3.org/2001/XMLSchema#string

P2860

Anaphylactic reaction to platelet transfusion as the initial symptom of an undiagnosed systemic mastocytosis: a case report and review of the literature

Mastocytosis.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis.

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell.

KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.

P304

e152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.14309/CRJ.2016.125

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27921051

http://www.w3.org/2001/XMLSchema#string

P932

5126489

http://www.w3.org/2001/XMLSchema#string

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

about

P2860

P2860

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932